articleNature MedicineFeb 5, 2026Closed access

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases

Bambino Gesù Children's Hospital · Istituti di Ricovero e Cura a Carattere Scientifico · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

8
total citations
FWCI
98.74
Percentile
100%
References
65
Too recent for citation history.

Authors

33

Topics & keywords

Keywords
  • Chimeric antigen receptor
  • Cytokine release syndrome
  • Discontinuation
  • Adverse effect
  • T cell
  • Immune system
  • Refractory (planetary science)
  • Clinical trial
No related works found for this paper.